225
Views
7
CrossRef citations to date
0
Altmetric
Review

Transdermal testosterone replacement therapy in men

, &
Pages 101-112 | Published online: 09 Jan 2014

Resources

References

  • Rao PM Kelly DM Jones TH Testosterone and insulin resistance in the metabolic syndrome and T2DM in men Nat Rev Endocrinol 2013 9 8 479 493 23797822
  • Kelly DM Jones TH Testosterone: a vascular hormone in health and disease J Endocrinol 2013 217 3 R47 R71 23549841
  • Giannoulis MG Martin FC Nair KS Umpleby AM Sonksen P Hormone replacement therapy and physical function in healthy older men. Time to talk hormones? Endocr Rev 2012 33 3 314 377 22433122
  • Shi Z Araujo AB Martin S O’Loughlin P Wittert G Longitudinal changes in testosterone over five years in community-dwelling men J Clin Endocrinol Metab 2013 98 8 3289 3297 23775354
  • Chin K-Y Ima-Nirwana S Mohamed IN Aminuddin A Ngah WZW Total testosterone and sex hormone-binding globulin are significantly associated with metabolic syndrome in middle-aged and elderly men Exp Clin Endocrinol Diabetes 2013 121 7 407 412 23765753
  • Yeap BB Alfonso H Chubb SA In older men an optimal plasma testosterone is associated with reduced all-cause mortality and higher dihydrotestosterone with reduced ischemic heart disease mortality, while estradiol levels do not predict mortality J Clin Endocrinol Metab 2013 11 20 [Epub ahead of print]
  • Kaufman JM Vermeulen A The decline of androgen levels in elderly men and its clinical and therapeutic implications Endocr Rev 2005 26 6 833 876 15901667
  • Harman SM Metter EJ Tobin JD Pearson J Blackman MR Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging J Clin Endocrinol Metab 2001 86 2 724 731 11158037
  • Feldman HA Longcope C Derby CA Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study J Clin Endocrinol Metab 2002 87 2 589 598 11836290
  • Araujo AB Esche GR Kupelian V Prevalence of symptomatic androgen deficiency in men J Clin Endocrinol Metab 2007 92 11 4241 4247 17698901
  • Wang C Nieschlag E Swerdloff R Investigation, treatment and monitoring of late-onset hypogonadism in males Int J Androl 2009 32 1 1 10 18798761
  • Al-Futaisi AM Al-Zakwani IS Almahrezi AM Morris D Subcutaneous administration of testosterone. A pilot study report Saudi Med J 2006 27 1843 1846 17143361
  • Szeinbach SL Seoane-Vazquez E Summers KH Development of a men’s Preference for Testosterone Replacement Therapy (P-TRT) instrument Patient Prefer Adherence 2012 6 631 641 22969294
  • Gagnier JJ Kienle G Altman DG Moher D Sox H Riley D CARE group The CARE guidelines: consensus-based clinical case reporting guideline development BMJ Case Rep 2013 2013
  • Gagnier JJ Kienle G Altman DG Moher D Sox H Riley D the CARE group The CARE guidelines: consensus-based clinical case report guideline development J Clin Epidemiol Epub 9 11 2013
  • Dandona P Rosenberg MT A practical guide to male hypogonadism in the primary care setting Int J Clin Pr 2010 64 6 682 696
  • Griffin JE Wilson JD Disorders of the testis and male reproductive tract Larsen PR Kronenberg HM Melmed S Polonsky KS William’s Textbook of Endocrinology 10th ed New York WB Saunders 2003 709 770
  • Ohl DA Quallich SA Clinical hypogonadism and androgen replacement therapy: an overview Urol Nurs 2006 26 4 253 259 269 quiz 260 16939042
  • Hall JE Reproductive and Hormonal Functions of the Male Guyton and Hall Textbook of Medical Physiology 12th ed New York Elsevier 2010
  • Hayes FJ Seminara SB Decruz S Boepple PA Crowley WF Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback J Clin Endocrinol Metab 2000 85 9 3027 3035 10999781
  • Falahati-Nini A Riggs BL Atkinson EJ O’Fallon WM Eastell R Khosla S Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men J Clin Invest 2000 106 12 1553 1560 11120762
  • Khosla S Melton LJ Atkinson EJ O’Fallon WM Klee GG Riggs BL Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen J Clin Endocrinol Metab 1998 83 7 2266 2274 9661593
  • Tracz MJ Sideras K Boloña ER Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials J Clin Endocrinol Metab 2006 91 6 2011 2016 16720668
  • Ferlin A Selice R Carraro U Foresta C Testicular function and bone metabolism – beyond testosterone Nat Rev Endocrinol 2013 9 9 548 554 23856820
  • Sinnesael M Claessens F Boonen S Vanderschueren D Novel insights in the regulation and mechanism of androgen action on bone Curr Opin Endocrinol Diabetes Obes 2013 20 3 240 244 23449008
  • Rodriguez-Tolrà J Torremadé J di Gregorio S Del Rio L Franco E Effects of testosterone treatment on bone mineral density in men with testosterone deficiency syndrome Andrology 2013 1 4 570 575 23686863
  • Meinhardt U Mullis PE The essential role of the aromatase/p450arom Semin Reprod Med 2002 20 3 277 284 12428207
  • Vermeulen A Kaufman JM Goemaere S van Pottelberg I Estradiol in elderly men Aging Male 2002 5 2 98 102 12198740
  • Mauvais-Jarvis F Clegg DJ Hevener AL The role of estrogens in control of energy balance and glucose homeostasis Endocr Rev 2013 34 3 309 338 23460719
  • Chrousos GP Stress and disorders of the stress system Nat Rev Endocrinol 2009 5 7 374 381 19488073
  • Blick G Khera M Bhattacharya RK Kushner H Miner MM Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry Postgrad Med 2013 125 2 19 29 23816768
  • Yeap BB Alfonso H Chubb SAP Reference ranges and determinants of testosterone, dihydrotestosterone, and estradiol levels measured using liquid chromatography-tandem mass spectrometry in a population-based cohort of older men J Clin Endocrinol Metab 2012 97 11 4030 4039 22977273
  • Longcope C Kato T Horton R Conversion of blood androgens to estrogens in normal adult men and women J Clin Invest 1969 48 12 2191 2201 5355335
  • Finkelstein JS Lee H Burnett-Bowie S-AM Gonadal steroids and body composition, strength, and sexual function in men N Engl J Med 2013 369 11 1011 1022 24024838
  • Simanainen U Brogley M Gao YR Length of the human androgen receptor glutamine tract determines androgen sensitivity in vivo Mol Cell Endocrinol 2011 342 1–2 81 86 21664242
  • Wang C Swerdloff R Kipnes M New testosterone buccal system (Striant) delivers physiological testosterone levels: pharmacokinetics study in hypogonadal men J Clin Endocrinol Metab 2004 89 8 3821 3829 15292312
  • Gooren LJ Advances in testosterone replacement therapy Front Horm Res 2009 37 32 51 19011287
  • Morales A Johnston B Heaton JPW Lundie M Testosterone supplementation for hypogonadal impotence: assessment of biochemical measures and therapeutic outcomes J Urol 1997 157 3 849 854 9072584
  • Snyder PJ Lawrence DA Treatment of male hypogonadism with testosterone enanthate J Clin Endocrinol Metab 1980 51 6 1335 1339 6777395
  • Smith RP Khanna A Coward RM Factors influencing patient decisions to initiate and discontinue subcutaneous testosterone pellets (testopel) for treatment of hypogonadism J Sex Med 2013 10 9 2326 2333 23859250
  • Ullah MI Washington T Kazi M Tamanna S Koch CA Testosterone deficiency as a risk factor for cardiovascular disease Horm Metab Res 2011 43 3 153 164 21283952
  • Koch CA Zitzmann M Testosterone deficiency or male hypogonadism Koch CA Chrousos GP Contemporary Endocrinology: Endocrine Hypertension New York Springer 2013
  • Basaria S Dobs AS New modalities of transdermal testosterone replacement Treat Endocrinol 2003 2 1 1 9 15871550
  • Gooren LJ Bunck MC Androgen replacement therapy: present and future Drugs 2004 64 17 1861 1891 15329035
  • Swerdloff RS Wang C Androgens and the ageing male Best Pract Res Clin Endocrinol Metab 2004 18 3 349 362 15261842
  • Bouloux P Testim 1% testosterone gel for the treatment of male hypogonadism Clin Ther 2005 27 3 286 298 15878382
  • Hong BS Ahn TY Recent trends in the treatment of testosterone deficiency syndrome Int J Urol 2007 14 11 981 985 17956520
  • Jones TH Testosterone replacement therapy Br J Hosp Med (Lond) 2007 68 10 547 553 17974303
  • Srinivas-Shankar U Sharma D Testosterone treatment in elderly men Adv Ther 2009 26 1 25 39 19198768
  • Corona G Rastrelli G Forti G Maggi M Update in testosterone therapy for men J Sex Med 2011 8 3 639 654 quiz 655 21711483
  • Giagulli VA Triggiani V Corona G Evidence-based medicine update on testosterone replacement therapy (TRT) in male hypogonadism: focus on new formulations Curr Pharm Des 2011 17 15 1500 1511 21521164
  • Abadilla KA Dobs AS Topical testosterone supplementation for the treatment of male hypogonadism Drugs 2012 72 12 1591 1603 22867042
  • Dinsmore WW Wyllie MG The long-term efficacy and safety of a testosterone mucoadhesive buccal tablet in testosterone-deficient men BJU Int 2012 110 2 162 169 22288877
  • Jenerowicz D Polańska A Olek-Hrab K Silny W Skin hypersensitivity reactions to transdermal therapeutic systems – still an important clinical problem Ginekol Pol 2012 83 1 46 50 22384639
  • Foco A Hadziabdic J Becic F Transdermal drug delivery systems Med Arch 2004 58 4 230 234
  • Cunningham GR Cordero E Thornby JI Testosterone replacement with transdermal therapeutic systems. Physiological serum testosterone and elevated dihydrotestosterone levels JAMA 1989 261 17 2525 2530 2704112
  • Eisenegger C Von Eckardstein A Fehr E Von Eckardstein S Pharmacokinetics of testosterone and estradiol gel preparations in healthy young men Psychoneuroendocrinology 2013 38 171 178 22721608
  • Bhasin S Cunningham GR Hayes FJ Task Force, Endocrine Socity Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline J Clin Endocrinol Metab 2010 95 6 2536 2559 20525905
  • Wang C Ilani N Arver S McLachlan RI Soulis T Watkinson A Efficacy and safety of the 2% formulation of testosterone topical solution applied to the axillae in androgen-deficient men Clin Endocrinol 2011 75 6 836 843
  • Abadilla KA Dobs AS Topical testosterone supplementation for the treatment of male hypogonadism Drugs 2012 72 12 1591 1603 22867042
  • Dobs AS McGettigan J Norwood P Howell J Waldie E Chen Y A novel testosterone 2% gel for the treatment of hypogonadal males J Androl 2012 33 4 601 607 21979302
  • McNicholas T Ong T Review of Testim gel Expert Opin Pharmacother 2006 7 4 477 484 16503819
  • Marbury T Hamill E Bachand R Sebree T Smith T Evaluation of the pharmacokinetic profiles of the new testosterone topical gel formulation, Testim, compared to AndroGel Biopharm Drug Dispos 2003 24 3 115 120 12673669
  • Amory JK Watts NB Easley KA Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone J Clin Endocrinol Metab 2004 89 2 503 510 14764753
  • Calof OM Singh AB Lee ML Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials J Gerontol A Biol Sci Med Sci 2005 60 11 1451 1457 16339333
  • Fernández-Balsells MM Murad MH Lane M Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis J Clin Endocrinol Metab 2010 95 6 2560 2575 20525906
  • Shabsigh R Crawford ED Nehra A Slawin KM Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review Int J Impot Res 2009 21 1 9 23 18633357
  • Burnett AL Kan-Dobrosky N Miller MG Testosterone replacement with 1% testosterone gel and priapism: no definite risk relationship J Sex Med 2013 10 4 1151 1161 23347341
  • Morrison BF Reid M Madden W Burnett AL Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report Andrology 2013 1 4 576 582 23606509
  • Francomano D Ilacqua A Bruzziches R Lenzi A Aversa A Effects of 5-year treatment with testosterone undecanoate on lower urinary tract symptoms in obese men with hypogonadism and metabolic syndrome Urology Epub 10 15 2013
  • Yassin D-J El Douaihy Y Yassin AA Kashanian J Shabsigh R Hammerer PG Lower urinary tract symptoms improve with testosterone replacement therapy in men with late-onset hypogonadism: 5-year prospective, observational and longitudinal registry study World J Urol Epub 10 18 2013
  • Accessdata FDA Available at: http://www.accessdata.fda.gov/drug-satfda_docs/label/2002/21454lbl.pdf Accessed November 10, 2013
  • Kunz GJ Virilization of young children after topical androgen use by their parents Pediatrics 2004 114 1 282 284 15231947
  • Bhasin S Cunningham GR Hayes FJ Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline J Clin Endocrinol Metab 2006 91 6 1995 2010 16720669
  • Di Luigi L Sgrò P Aversa A Concerns about serum androgens monitoring during testosterone replacement treatments in hypogonadal male athletes: a pilot study J Sex Med 2012 9 3 873 886 22321254
  • Wang C Swerdloff RS Iranmanesh A Testosterone Gel Study Group Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men J Clin Endocrinol Metab 2000 85 8 2839 2853 10946892
  • Saad F Aversa A Isidori AM Zafalon L Zitzmann M Gooren L Onset of effects of testosterone treatment and time span until maximum effects are achieved Eur J Endocrinol 2011 165 5 675 685 21753068
  • Miner MM Bhattacharya RK Blick G Kushner H Khera M 12-Month observation of testosterone replacement effectiveness in a general population of men Postgrad Med 2013 125 2 8 18 23816767
  • Heufelder AE Saad F Bunck MC Gooren L Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone J Androl 2009 30 6 726 733 19578132
  • Hijazi RA Cunningham GR Andropause: is androgen replacement therapy indicated for the aging male? Annu Rev Med 2005 56 117 137 15660505
  • Malkin CJ Pugh PJ Jones RD Kapoor D Channer KS Jones TH The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men J Clin Endocrinol Metab 2004 89 7 3313 3318 15240608
  • Ginzburg E Klimas N Parvus C Long-term safety of testosterone and growth hormone supplementation: a retrospective study of metabolic, cardiovascular, and oncologic outcomes J Clin Med Res 2010 2 4 159 166 21629532
  • Emmelot-Vonk MH Verhaar HJJ Nakhai Pour HR Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial JAMA 2008 299 39 52 18167405
  • Wang C Swerdloff RS Iranmanesh A Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men Clin Endocrinol 2001 54 6 739 750
  • Bhattacharya RK Khera M Blick G Kushner H Nguyen D Miner MM Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS) BMC Endocr Disord 2011 11 1 18 22044661
  • Guo W Bachman E Li M Testosterone administration inhibits hepcidin transcription and is associated with increased iron incorporation into red blood cells Aging Cell 2013 12 2 280 291 23399021
  • Marchioli R Finazzi G Specchia G CYTO-PV Collaborative Group Cardiovascular events and intensity of treatment in polycythemia vera N Engl J Med 2013 368 1 22 33 23216616
  • Spivak JL Polycythemia vera, the hematocrit, and blood-volume physiology N Engl J Med 2013 368 1 76 78 23216617
  • Wells RE Merrill EW Influence of flow properties of blood upon viscosity-hematocrit relationships J Clin Invest 1962 41 1591 1598 14040228
  • Schoenfeld MJ Shortridge E Cui Z Muram D Medication adherence and treatment patterns for hypogonadal patients treated with topical testosterone therapy: a retrospective medical claims analysis J Sex Med 2013 10 5 1401 1409 23464534
  • Grober ED Khera M Soni SD Espinoza MG Lipshultz LI Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men Int J Impot Res 2008 20 2 213 217 17898800